Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation-Reference-Cited by-同舟云学术

Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation

Published:2024-01 Issue:1 Volume:8 Page:102285
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Campos-Staffico Alessandra M.,Jacoby Juliet P.,Dorsch Michael P.,Limdi Nita A.,Barnes Geoffrey D.,Luzum Jasmine A.

Funder

National Institute on Aging

Boston Scientific Corporation

National Heart, Lung, and Blood Institute

Agency for Healthcare Research and Quality

American Heart Association

NCATS

National Institutes of Health

Michigan Institute for Clinical and Health Research

Publisher

Elsevier BV

Subject

Hematology

Reference40 articles.

1. Burden of atrial fibrillation–associated ischemic stroke in the United States;Alkhouli;JACC Clin Electrophysiol,2018

2. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

3. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

4. Comparative safety and effectiveness of oral anticoagulants in nonvalvular atrial fibrillation: the NAXOS study;Van Ganse;Stroke,2020

5. Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database;Munir;J Interv Card Electrophysiol,2023